May 2010 - Volume 16 - Issue 5
pp: 721-902

Effect of EP4 agonist (ONO-4819CD) for patients with mild to moderate ulcerative colitis refractory to 5-aminosalicylates: A randomized phase II, placebo-controlled trial

Nakase, Hiroshi; Fujiyama, Yoshihide; Oshitani, Nobuhide; More

Inflammatory Bowel Diseases. 16(5):731-733, May 2010.

Nutriose, a prebiotic low-digestible carbohydrate, stimulates gut mucosal immunity and prevents TNBS-induced colitis in piglets

Pouillart, Philippe R.; Dépeint, Flore; Abdelnour, Afif; More

Inflammatory Bowel Diseases. 16(5):783-794, May 2010.

Mapping of inflammatory bowel disease in northern France: Spatial variations and relation to affluence

Declercq, Christophe; Gower-Rousseau, Corinne; Vernier-Massouille, Gwénola; More

Inflammatory Bowel Diseases. 16(5):807-812, May 2010.

Fine-scale geographic variations of inflammatory bowel disease in France: Correlation with socioeconomic and house equipment variables

Nerich, Virginie; Monnet, Elisabeth; Weill, Alain; More

Inflammatory Bowel Diseases. 16(5):813-821, May 2010.

Ulcerative colitis in a Southern European country: A national perspective

Portela, Francisco; Magro, Fernando; Lago, Paula; More

Inflammatory Bowel Diseases. 16(5):822-829, May 2010.

Lipopolysaccharide exposure is linked to activation of the acute phase response and growth failure in pediatric Crohn's disease and murine colitis

Pasternak, Brad A.; D'Mello, Sharon; Jurickova, Ingrid I.; More

Inflammatory Bowel Diseases. 16(5):856-869, May 2010.

1 2 3 4 5